Kezar Life Sciences Statistics
Total Valuation
KZR has a market cap or net worth of $54.55 million. The enterprise value is -$15.00 million.
Important Dates
The next estimated earnings date is Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KZR has 7.37 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | 7.37M |
| Shares Outstanding | 7.37M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 2.16% |
| Owned by Institutions (%) | 42.15% |
| Float | 5.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.77 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.52, with a Debt / Equity ratio of 0.03.
| Current Ratio | 11.52 |
| Quick Ratio | 11.23 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -58.08 |
Financial Efficiency
Return on equity (ROE) is -59.93% and return on invested capital (ROIC) is -31.80%.
| Return on Equity (ROE) | -59.93% |
| Return on Assets (ROA) | -29.52% |
| Return on Invested Capital (ROIC) | -31.80% |
| Return on Capital Employed (ROCE) | -74.59% |
| Weighted Average Cost of Capital (WACC) | 7.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.02M |
| Employee Count | 55 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.08% in the last 52 weeks. The beta is 0.43, so KZR's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +64.08% |
| 50-Day Moving Average | 6.61 |
| 200-Day Moving Average | 5.43 |
| Relative Strength Index (RSI) | 64.02 |
| Average Volume (20 Days) | 82,492 |
Short Selling Information
The latest short interest is 192,306, so 2.61% of the outstanding shares have been sold short.
| Short Interest | 192,306 |
| Short Previous Month | 176,056 |
| Short % of Shares Out | 2.61% |
| Short % of Float | 3.73% |
| Short Ratio (days to cover) | 4.73 |
Income Statement
| Revenue | n/a |
| Gross Profit | -33.76M |
| Operating Income | -52.27M |
| Pretax Income | -56.03M |
| Net Income | -56.03M |
| EBITDA | -51.37M |
| EBIT | -52.27M |
| Earnings Per Share (EPS) | -$7.66 |
Full Income Statement Balance Sheet
The company has $71.88 million in cash and $2.33 million in debt, with a net cash position of $69.55 million or $9.44 per share.
| Cash & Cash Equivalents | 71.88M |
| Total Debt | 2.33M |
| Net Cash | 69.55M |
| Net Cash Per Share | $9.44 |
| Equity (Book Value) | 70.07M |
| Book Value Per Share | 9.56 |
| Working Capital | 69.16M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$51.78 million and capital expenditures -$8,000, giving a free cash flow of -$51.79 million.
| Operating Cash Flow | -51.78M |
| Capital Expenditures | -8,000 |
| Depreciation & Amortization | 897,000 |
| Net Borrowing | -10.65M |
| Free Cash Flow | -51.79M |
| FCF Per Share | -$7.03 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KZR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | -102.72% |
| FCF Yield | -94.93% |
Analyst Forecast
The average price target for KZR is $6.00, which is -18.92% lower than the current price. The consensus rating is "Hold".
| Price Target | $6.00 |
| Price Target Difference | -18.92% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -41.38% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 30, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |